Fluarix Tetra

BIOLOGICAL7 trials

Sponsors

GlaxoSmithKline, University of Surrey, Medigen Vaccine Biologics Corp., The University of Hong Kong, ModernaTX, Inc.

Conditions

InfluenzaSeasonal Influenza

Phase 2

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

CompletedNCT05734040

OsivaxInfluenza

Start: 2023-05-10End: 2024-01-15Updated: 2024-01-25

Phase 3

Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above

CompletedNCT02369341

GlaxoSmithKlineInfluenza

Start: 2015-04-29End: 2015-06-03Updated: 2017-10-09

A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine

CompletedNCT03718468

Medigen Vaccine Biologics Corp.Influenza

Start: 2018-10-30End: 2019-07-03Updated: 2019-08-14

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

CompletedNCT05415462

ModernaTX, Inc.Seasonal Influenza

Start: 2022-06-06End: 2023-09-04Updated: 2024-09-24

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

CompletedNCT06602024

ModernaTX, Inc.Seasonal Influenza

Start: 2024-09-16End: 2025-08-21Updated: 2025-09-10

Unknown Phase

T-cell Diversity Following Intranasal and Intramuscular Vaccines

CompletedNCT02557802

University of SurreyInfluenza

Start: 2015-10-31End: 2016-01-31Target: 30Updated: 2016-01-26

Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children

The University of Hong KongInfluenza

Start: 2022-04-30End: 2023-10-30Target: 72Updated: 2022-04-18

Related Papers

229. mRNA-1010, an mRNA-Based Influenza Vaccine, is Safe and Efficacious in Adults Aged ≥50 Years

Open Forum Infectious Diseases2026-01-01

Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine

Vaccines2025-05-231 citations

An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers

Human Vaccines & Immunotherapeutics2025-04-0213 citations

Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial

The Journal of Infectious Diseases2024-06-2737 citations

Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis.

2023-06-1984 citations

Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil.

2016-11-294 citations